levodopa has been researched along with Dementia Praecox in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 60 (69.77) | 18.7374 |
1990's | 9 (10.47) | 18.2507 |
2000's | 9 (10.47) | 29.6817 |
2010's | 7 (8.14) | 24.3611 |
2020's | 1 (1.16) | 2.80 |
Authors | Studies |
---|---|
Ares-Pensado, B; Fernández-Pajarín, G; Jiménez-Martín, I; Koukoulis, A; Sesar, A | 1 |
de Jong, MH; Van Gool, AR; Zemel, D | 1 |
Andreou, C; Moritz, S; Naber, D; Veckenstedt, R; Veith, K | 1 |
Apud, JA; Bigelow, LB; Das, S; Egan, MF; Goldberg, TE; Mattay, VS; Weickert, TW; Weinberger, DR | 1 |
Barbui, C; Bovi, T; Cannas, A; Ceravolo, R; Cipriani, A; Dallocchio, C; Di Stefano, A; Frosini, D; Luca, A; Marrosu, F; Matinella, A; Minafra, B; Morgante, F; Morgante, L; Nicoletti, A; Pacchetti, C; Rossi, S; Sciarretta, M; Solla, P; Tinazzi, M; Ulivelli, M; Zappia, M | 1 |
Fukuda, K | 1 |
Andreou, C; Kolbeck, K; Moritz, S | 1 |
Arakawa, R; Fujimura, Y; Ito, H; Kashima, H; Kato, M; Matsumoto, R; Nozaki, S; Okubo, Y; Okumura, M; Ota, M; Otsuka, A; Suhara, T; Takahashi, H; Takano, A; Takano, H; Yasuno, F | 1 |
Moncrieff, J | 1 |
Al Hadithy, AF; Alifirova, VM; Brouwers, JR; Fedorenko, OY; Freidin, MB; Govorin, NV; Ivanova, SA; Loonen, AJ; Pechlivanoglou, P; Rudikov, EV; Semke, AV; Sorokina, VA; Wilffert, B; Zhukova, IA | 1 |
Ohye, C; Shibazaki, T | 1 |
Abe, K; Hotta, K; Igarashi, K; Kasuya, F; Sakoda, S | 1 |
Carlsson, A; Gefvert, O; Lindström, LH; Tedroff, J; Waters, N; Waters, S | 1 |
Jaskiw, GE; Popli, AP | 1 |
Bezard, E; Carroll, P; Diaz, J; Griffon, N; Gross, C; Guillin, O; Lammers, C; Le Foll, B; Schwartz, JC; Sokoloff, P; Stark, H | 1 |
Bobkova, NV; Bondarenko, NA; Gudasheva, TA; Ostrovskaya, RU; Retyunskaya, MV; Samokhin, AN | 1 |
Alpert, M; Friedhoff, AJ | 1 |
Lloyd, KG; Worms, P | 1 |
Bunney, WE; Lerner, P; Sternberg, DE; VanKammen, DP | 1 |
Bodis-Wollner, I; Mylin, L; Thornton, J; Yahr, MD | 1 |
Haracz, JL | 1 |
Bjørndal, N; Casey, DE; Gerlach, J | 1 |
Hardie, RJ; Lees, AJ; Stern, GM | 1 |
Hadjiconstantinou, M; Neff, NH | 1 |
Gamaleia, NB | 1 |
Honda, Y; Kagono, Y; Kita, S; Saito, M; Suitsu, N | 1 |
Vasil'ev, VN | 1 |
Heinz, A; Pietzcker, A; Przuntek, H; Winterer, G | 1 |
Chouinard, G; Miller, R | 1 |
Cataneo, EA; Leiguarda, R; Manes, F; Merello, M; Petracca, G; Starkstein, S | 1 |
Ishiguro, T; Nisijima, K; Noguti, M | 1 |
Moerlein, SM; Perlmutter, JS | 1 |
Bergström, M; Gefvert, O; Hagberg, G; Hartvig, P; Långström, B; Lindström, LH; Lundberg, T | 1 |
Seeman, P | 1 |
Gerlach, J; Lühdorf, K | 1 |
Howard, JS | 1 |
Kishimoto, A; Nakao, T; Ogura, C | 1 |
Trimble, M | 1 |
Ringwald, E | 1 |
Hartmann, E; Keller-Teschke, M | 1 |
Gillin, JC; Murphy, GM; Staub, R; Tinklenberg, JR; Wyatt, RJ | 1 |
Lamprecht, F | 1 |
Hartmann, E | 1 |
Belmaker, RH; Berman, M; Biederman, J; Ebstein, RP; Stern, R; van Praag, HM | 1 |
Bellodi, L; Brambilla, F; Malagoli, G; Negri, F; Smeraldi, E | 1 |
Calil, HM; Hollister, LE; Yesavage, JA | 1 |
Angrist, B; Paquin, J; Rotrosen, J | 1 |
Anokhina, IP; Kudriavtsev, IA; Lukacher, GIa; Morozov, GV; Morozova, TG | 1 |
Angrist, B; Clark, C; Gershon, S; Halpers, FS; Rotrosen, J; Sachar, EJ | 1 |
Alpert, M; Diamond, F; Friedhoff, AJ; Marcos, LR | 1 |
Horvath, T; Meares, R | 1 |
Davis, JM; Janowsky, DS | 1 |
Baker, EP; Buchanan, FH; Parton, RV; Warren, JW | 1 |
Barry, VC; Klawans, HL | 1 |
Inanaga, K; Nagata, T; Ohshima, M; Yamauchi, I | 1 |
Angrist, BM; Gershon, S; Halpern, FS; Rotrosen, J; Sachar, EJ | 2 |
Bunney, WE | 1 |
Angrist, B; Gershon, S | 1 |
Snyder, SH | 1 |
Davis, JM; Frohman, LA; Pandey, G; Smith, RC; Tamminga, CA | 1 |
Kai, Y | 1 |
Yamauchi, M | 1 |
Tissot, R | 1 |
Inanaga, K; Inoue, K; Nakazawa, Y; Oshima, M; Tachibana, H | 1 |
Baldessarini, RJ | 1 |
Klawans, HL; Margolin, DI | 1 |
Angrist, B; Gershon, S; Shopsin, B | 1 |
Luchins, D | 1 |
Stimmel, GL | 1 |
Dworkin, RH; Opler, LA | 1 |
Christison, GW; Kirch, DG; Wyatt, RJ | 1 |
Jellinger, K; Pearce, RK; Seeman, P; Tourtellotte, WW | 1 |
Ludatscher, JI | 1 |
Pidgeon, JF; Wolf, MA | 1 |
Andreasen, NC | 1 |
Luchins, DJ; Meltzer, HY; Sommers, AA | 1 |
Annable, L; Chouinard, G; Mercier, P; Turnier, L | 1 |
Davidson, M; Davis, KL; Horvath, TB; Keefe, RS; Losonczy, MF; Mohs, RC; Siever, LJ | 1 |
Johansson, F; von Knorring, L | 1 |
Engstrom, FW | 1 |
Clarke, CE; Green, MH; Shand, D; Yuill, GM | 1 |
Berry, T | 1 |
Friedman, JH; Max, J; Swift, R | 1 |
Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E | 1 |
Davis, BM; Davis, KL; Horvath, TB; Johns, CA; Levy, MI; Mathé, AA; Mohs, RC; Rothpearl, AB | 1 |
13 review(s) available for levodopa and Dementia Praecox
Article | Year |
---|---|
A critique of the dopamine hypothesis of schizophrenia and psychosis.
Topics: Antipsychotic Agents; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Humans; Levodopa; Models, Neurological; Psychotic Disorders; Schizophrenia | 2009 |
A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Humans; Levodopa; Middle Aged; Schizophrenia | 2004 |
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Denervation; Depression; Dopamine; Dopamine Agents; Gene Expression Regulation, Developmental; Humans; Levodopa; Limbic System; Neuronal Plasticity; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia; Stress, Physiological | 2004 |
Neuropharmacological actions of GABA agonists: predictability for their clinical usefulness.
Topics: Antipsychotic Agents; Brain Chemistry; Dyskinesia, Drug-Induced; Epilepsy; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Muscular Diseases; Schizophrenia | 1981 |
Catecholamine systems of retina: a model for studying synaptic mechanisms.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Darkness; Dopamine; Electrophysiology; Enzyme Activation; Epinephrine; Evoked Potentials, Visual; gamma-Aminobutyric Acid; Humans; Levodopa; Light; Melatonin; Narcotics; Neurons; Norepinephrine; Parkinson Disease; Receptors, Adrenergic; Retina; Schizophrenia; Serotonin | 1984 |
Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
Topics: Antipsychotic Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Humans; Interneurons; Levodopa; Nerve Degeneration; Neurons; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Cholinergic; Receptors, Dopamine; Schizophrenia | 1993 |
PET measurements of dopaminergic pathways in the brain.
Topics: Adrenergic Fibers; Brain Diseases; Cerebrovascular Circulation; Dopamine; Dopamine Agents; Dystonia; Humans; Levodopa; Neural Pathways; Parkinson Disease; Radiopharmaceuticals; Receptors, Dopamine; Schizophrenia; Tomography, Emission-Computed | 1999 |
Atypical antipsychotics: mechanism of action.
Topics: Antipsychotic Agents; Drug Administration Schedule; Humans; Levodopa; Neural Pathways; Parkinson Disease; Psychoses, Substance-Induced; Receptors, Dopamine D2; Receptors, Serotonin; Schizophrenia | 2002 |
Epilepsy and schizophrenia: a neurochemical bridge.
Topics: Amphetamine; Anticonvulsants; Brain; Butyrophenones; Disulfiram; Dopamine; Dopamine beta-Hydroxylase; Epilepsy; Humans; Huntington Disease; Levodopa; Neurocognitive Disorders; Phenothiazines; Phenytoin; Receptors, Dopamine; Schizophrenia | 1977 |
On the role of dopamine in the pathophysiology of anorexia nervosa.
Topics: 17-Ketosteroids; Amphetamine; Anorexia Nervosa; Apomorphine; Compulsive Personality Disorder; Dopamine; Female; Glucose Tolerance Test; Gonadotropins, Pituitary; Humans; Levodopa; Luteinizing Hormone; Male; Movement Disorders; Parkinson Disease; Schizophrenia; Steroids; Thinness | 1976 |
Biological transmethylation involving S-adenosylmethionine: development of assay methods and implications for neuropsychiatry.
Topics: Acetylserotonin O-Methyltransferase; Animals; Apomorphine; Blood Platelets; Brain; Histamine; Humans; Leukemia; Levodopa; Methionine; Methionine Adenosyltransferase; Methyltransferases; Monoamine Oxidase Inhibitors; Pyrogallol; Rabbits; Rats; S-Adenosylmethionine; Schizophrenia; Serotonin; Tetrahydrofolates | 1975 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
[Dopanergic agonists and schizophrenia].
Topics: Bromocriptine; Dopamine Agents; Humans; Levodopa; Receptors, Dopamine; Schizophrenia | 1989 |
14 trial(s) available for levodopa and Dementia Praecox
Article | Year |
---|---|
Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.
Topics: Adult; Cognition; Cross-Over Studies; Decision Making; Delusions; Dopamine Agonists; Dopamine Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Judgment; Levodopa; Logic; Male; Schizophrenia; Schizophrenic Psychology; Young Adult | 2014 |
Antipsychotics decrease response confidence.
Topics: Adult; Antipsychotic Agents; Cross-Over Studies; Delusions; Dopamine Agents; Double-Blind Method; Female; Haloperidol; Humans; Levodopa; Male; Schizophrenia; Surveys and Questionnaires; Young Adult | 2016 |
Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine.
Topics: Adult; Analysis of Variance; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Cross-Over Studies; Double-Blind Method; Female; Humans; Levodopa; Motor Activity; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia | 1996 |
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.
Topics: Adult; Affect; Antipsychotic Agents; Anxiety; Basal Ganglia Diseases; Benserazide; Brief Psychiatric Rating Scale; Clinical Trials as Topic; Drug Combinations; Emotions; Humans; Hydrazines; Levodopa; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Social Behavior | 1975 |
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl | 1978 |
Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men.
Topics: Clinical Trials as Topic; Dopamine beta-Hydroxylase; Fusaric Acid; Humans; Levodopa; Male; Mental Disorders; Picolinic Acids; Placebos; Schizophrenia | 1977 |
Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms.
Topics: Acute Disease; Amphetamines; Clinical Trials as Topic; Dextroamphetamine; Humans; Levodopa; Methylphenidate; Schizophrenia; Schizophrenic Psychology | 1976 |
Double blind trial of L-dopa in chronic schizophrenia.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Humans; Levodopa; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia | 1975 |
Double-blind controlled study of L-Dopa therapy in schizophrenia.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Levodopa; Male; Middle Aged; Placebos; Schizophrenia; Tranquilizing Agents | 1975 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind Method; Electroconvulsive Therapy; Humans; Levodopa; Lithium; Propranolol; Reserpine; Schizophrenia | 1991 |
Stable remission of tardive dyskinesia by L-dopa.
Topics: Adult; Aged; Antipsychotic Agents; Carbidopa; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia | 1989 |
The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Topics: Alprazolam; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Propranolol; Psychiatric Status Rating Scales; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology | 1986 |
Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
Topics: Adult; Antipsychotic Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Procyclidine; Pyrrolidines; Schizophrenia | 1987 |
Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems.
Topics: Acute Disease; Adult; Age Factors; Apomorphine; Carbidopa; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Research Design; Schizophrenia; Schizophrenic Psychology; Sodium Chloride | 1985 |
60 other study(ies) available for levodopa and Dementia Praecox
Article | Year |
---|---|
[Subthalamic deep brain stimulation in a case of idiopathic Parkinson's disease and schizophrenia].
Topics: Antipsychotic Agents; Deep Brain Stimulation; Humans; Levodopa; Male; Parkinson Disease; Schizophrenia | 2023 |
Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.
Topics: Antiparkinson Agents; Antipsychotic Agents; Brain; Carbidopa; Catechols; Clozapine; Diagnosis, Differential; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
Topics: Adult; Aged; Association Learning; Dopamine Agents; Female; Humans; Learning Disabilities; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2013 |
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Topics: Adult; Age Factors; Aged; Chi-Square Distribution; Disease Progression; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinsonian Disorders; Predictive Value of Tests; Protein Binding; Schizophrenia; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Tropanes | 2014 |
Integrated theory to unify status among schizophrenia and manic depressive illness.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine | 2015 |
Regional dopamine synthesis in patients with schizophrenia using L-[beta-11C]DOPA PET.
Topics: Adult; Brain Mapping; Carbon Radioisotopes; Chi-Square Distribution; Dopamine; Dopamine Agents; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Schizophrenia; Young Adult | 2009 |
NMDA receptor genotypes associated with the vulnerability to develop dyskinesia.
Topics: Age of Onset; Alleles; Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Gene Expression; Genetic Predisposition to Disease; Genotype; Humans; Huntington Disease; Levodopa; Long-Term Care; Motor Cortex; Movement Disorders; Polymorphism, Single Nucleotide; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2012 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulation; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Reoperation; Retrospective Studies; Schizophrenia; Stereotaxic Techniques; Sulpiride; Torticollis; Treatment Outcome; Tremor; Ventral Thalamic Nuclei | 2001 |
Determination of cabergoline and L-dopa in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Adult; Cabergoline; Case-Control Studies; Chromatography, Liquid; Dopamine Agonists; Ergolines; Humans; Levodopa; Middle Aged; Reproducibility of Results; Schizophrenia; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine.
Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Dopamine Agents; Haloperidol; Humans; Least-Squares Analysis; Levodopa; Principal Component Analysis; Schizophrenia; Tomography, Emission-Computed | 2003 |
Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Benserazide; Drug Combinations; Levodopa; Male; Memory; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neurotensin; Olfactory Bulb; Peptides; Rats; Rats, Wistar; Receptors, Muscarinic; Schizophrenia; Scopolamine; Space Perception | 2005 |
An un-dopamine hypothesis of schizophrenia.
Topics: Antipsychotic Agents; Dopamine; Humans; Levodopa; Receptors, Dopamine; Schizophrenia | 1980 |
Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
Topics: Antipsychotic Agents; Disulfiram; Dopamine beta-Hydroxylase; Fusaric Acid; Humans; Levodopa; Schizophrenia | 1982 |
Dopaminergic deficiency and delayed visual evoked potentials in humans.
Topics: Adult; Antipsychotic Agents; Carbidopa; Dopamine; Drug Therapy, Combination; Evoked Potentials, Visual; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenothiazines; Schizophrenia | 1982 |
The dopamine hypothesis: an overview of studies with schizophrenic patients.
Topics: Adenylyl Cyclases; Brain; Catechol O-Methyltransferase; Dextroamphetamine; Dopa Decarboxylase; Dopamine; Dopamine beta-Hydroxylase; Homovanillic Acid; Humans; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Receptors, Dopamine; Schizophrenia; Synapses; Tyrosine 3-Monooxygenase | 1982 |
Levodopa and receptor sensitivity modification in tardive dyskinesia.
Topics: Adult; Aged; Antipsychotic Agents; Benserazide; Bipolar Disorder; Dementia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Receptors, Dopamine; Schizophrenia | 1982 |
Sustained levodopa therapy in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia | 1983 |
[Catecholamine and indoleamine metabolism in groups of patients with paranoid and simple forms of schizophrenia].
Topics: Adult; Biogenic Amines; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Norepinephrine; Schizophrenia; Schizophrenia, Paranoid; Serotonin | 1981 |
Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients.
Topics: Adolescent; Amantadine; Brain; Computers; Electroencephalography; Female; Glycolates; Haloperidol; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Pyramidal Tracts; Reference Values; Schizophrenia; Thiophenes; Trihexyphenidyl | 1982 |
[Clinical application of insulin and L-dopa tests for evaluating the sympathico-adrenal system].
Topics: Adrenal Glands; Adult; Aged; Humans; Hypertension; Insulin; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia; Stomach Ulcer; Sympathetic Nervous System | 1980 |
[Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms].
Topics: Aged; Brain; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusion Pumps; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission | 1995 |
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Dopamine Agents; Female; Humans; Injections, Intravenous; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia | 1997 |
Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
Topics: Adult; Corpus Striatum; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Prefrontal Cortex; Schizophrenia; Time Factors; Tomography, Emission-Computed | 1999 |
Somatic profiles in chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Folic Acid Deficiency; Haloperidol; Humans; Hypoglycemia; Hypothyroidism; Iodine Radioisotopes; Levodopa; Middle Aged; Phenothiazines; Schizophrenia | 1976 |
Clinical effect of L-dopa on schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 1976 |
The relationship between epilepsy and schizophrenia: a biochemical hypothesis.
Topics: Amphetamines; Antipsychotic Agents; Brain; Dopamine; Epilepsy; Humans; Levodopa; Phenothiazines; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia | 1977 |
Phenylethylamine in rhesus monkeys: interactions with alpha-methyl-para-tyrosine and l-dopa.
Topics: Animals; Behavior, Animal; Dopamine; Drug Antagonism; Eye Movements; Haplorhini; Humans; Levodopa; Macaca; Macaca mulatta; Methyltyrosines; Models, Biological; Motor Activity; Phenethylamines; Phenobarbital; Schizophrenia; Stereotyped Behavior | 1979 |
Schizophrenia: a theory.
Topics: Cognition; Dopamine; Dopamine beta-Hydroxylase; Dreams; Feedback; Fusaric Acid; Humans; Levodopa; Models, Psychological; Movement Disorders; Norepinephrine; Schizophrenia; Schizophrenic Psychology; Sleep, REM; Stress, Psychological | 1976 |
The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
Topics: Adult; Aged; Cyclic AMP; Cyclic GMP; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Propranolol; Schizophrenia | 1978 |
Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuli.
Topics: Adult; Female; Growth Hormone; Haloperidol; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia | 1979 |
Low dose levodopa in schizophrenia.
Topics: Adult; Growth Hormone; Humans; Levodopa; Male; Psychiatric Status Rating Scales; Schizophrenia | 1977 |
Neuroendocrine studies with dopamine agonists in schizophrenia.
Topics: Adult; Apomorphine; Growth Hormone; Humans; Levodopa; Male; Receptors, Dopamine; Schizophrenia | 1978 |
[Treatment of reactive stuporous states with L-DOPA].
Topics: Adult; Antidepressive Agents; Catecholamines; Cognition Disorders; Consciousness Disorders; Humans; Levodopa; Middle Aged; Psychotic Disorders; Schizophrenia; Syndrome | 1978 |
Suppression of prolactin by dopamine agonists in schizophrenics and controls.
Topics: Adult; Apomorphine; Chronic Disease; Depression, Chemical; Dopamine; Humans; Levodopa; Male; Prolactin; Schizophrenia | 1978 |
Paradoxical reaction to L-dopa in schizophrenic patients.
Topics: Adult; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1978 |
The sensory filter in schizophrenia: a study of habituation, arousal, and the dopamine hypothesis.
Topics: Acoustic Stimulation; Adolescent; Adult; Arousal; Conditioning, Classical; Dopamine; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Heart Rate; Humans; Levodopa; Male; Middle Aged; Neurotic Disorders; Orientation; Schizophrenia; Schizophrenia, Paranoid | 1979 |
Behavioral effects of L-dopa and thyrotropin-releasing hormone in schizophrenic patients: a preliminary report.
Topics: Adult; Female; Humans; Levodopa; Male; Middle Aged; Schizophrenia; Thyrotropin-Releasing Hormone | 1975 |
Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.
Topics: Adult; Apomorphine; Growth Hormone; Humans; Levodopa; Male; Receptors, Dopamine; Schizophrenia | 1976 |
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia | 1977 |
Neuroendocrine assessment of dopaminergic activity in schizophrenia.
Topics: Adult; Apomorphine; Dopamine; Growth Hormone; Humans; Levodopa; Male; Schizophrenia | 1977 |
Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects.
Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Levodopa; Male; Paranoid Disorders; Piribedil; Psychoses, Substance-Induced; Schizophrenia | 1977 |
Biochemical factors in Schizophrenia.
Topics: Amphetamines; Animals; Binding Sites; Brain; Cocaine; Dopamine; Humans; Levodopa; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
A neuroendocrine study of supersensitivity in tardive dyskinesia.
Topics: Adult; Apomorphine; Chronic Disease; Dyskinesia, Drug-Induced; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Prolactin; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents | 1977 |
The effect of L-dopa and vitamin B6 in schizophrenia.
Topics: Adult; Alpha Rhythm; Chronic Disease; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Psychotropic Drugs; Pyridoxine; Schizophrenia; Schizophrenia, Catatonic; Schizophrenia, Disorganized | 1976 |
Effects of L-dopa and vitamin B6 on electroencephalograms of schizophrenic patients: a preliminary report.
Topics: Adult; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Pyridoxine; Schizophrenia | 1976 |
[Hypothetical concept: the physiopathological entity of monoaminergic psychoses].
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Behavior, Animal; Bipolar Disorder; Blood-Brain Barrier; Catecholamines; Diet; Humans; Levodopa; Neurons; Rats; Schizophrenia; Serotonin; Sexual Behavior; Tryptophan; Tyrosine | 1975 |
Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.
Topics: Amphetamine; Animals; Apomorphine; Behavior; Behavior, Animal; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Levodopa; Movement Disorders; Psychoses, Substance-Induced; Reaction Time; Receptors, Drug; Schizophrenia; Stereotyped Behavior; Substance-Related Disorders | 1975 |
Drugs, diagnosis, and disease.
Topics: Acetylcholine; Amphetamines; Bipolar Disorder; Humans; Imipramine; Levodopa; Lithium; Methylphenidate; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Schizophrenia; Time Factors | 1975 |
The dopamine hypothesis of schizophrenia. A critical analysis.
Topics: Acetylcholine; Amphetamine; Apomorphine; Cocaine; Dopamine; Electroconvulsive Therapy; gamma-Aminobutyric Acid; Humans; Levodopa; Methyldopa; Methyltyrosines; Models, Neurological; Psychoses, Substance-Induced; Schizophrenia; Tranquilizing Agents | 1975 |
Neuroleptics and the corpus striatum: clinical implications.
Topics: Acetylcholine; Basal Ganglia Diseases; Benztropine; Corpus Striatum; Dopamine; Fluphenazine; Haloperidol; Humans; Levodopa; Models, Neurological; Movement Disorders; Parkinson Disease; Reserpine; Schizophrenia; Tranquilizing Agents; Trihexyphenidyl | 1976 |
Simple schizophrenia, negative symptoms, and prefrontal hypodopaminergia.
Topics: Dopamine; Frontal Lobe; Humans; Levodopa; Mazindol; Schizophrenia; Schizophrenic Psychology | 1992 |
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Binding Sites; Dopamine; Female; Humans; Levodopa; Ligands; Male; Middle Aged; Parkinson Disease; Piperazines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia | 1990 |
Negative syndrome in schizophrenia: strategies for long-term management.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Electroconvulsive Therapy; Humans; Levodopa; Psychotropic Drugs; Schizophrenia; Syndrome | 1985 |
L-dopa challenge and relapse in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Dopamine; Hospitalization; Humans; Levodopa; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Risk; Schizophrenia; Schizophrenic Psychology | 1987 |
Changes in serum prolactin after electroconvulsive and epileptic seizures.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Epilepsy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Schizophrenia | 1987 |
Ethical issues in drug studies.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Ethics, Medical; Humans; Levodopa; Research; Schizophrenia; Schizophrenic Psychology | 1988 |
Clinical spectrum of neuroleptic malignant syndrome.
Topics: Adult; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Tranquilizing Agents | 1988 |
L-dopa for the negative symptoms of schizophrenia.
Topics: Drug Therapy, Combination; Humans; Levodopa; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Trifluoperazine | 1988 |
Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and L-dopa.
Topics: Adult; Carbidopa; Clozapine; Dibenzazepines; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Schizophrenia | 1987 |
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors | 1985 |